Literature DB >> 25743126

Non-specific anti-viral approach towards Ebola virus infection: a comment on "Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis".

Beuy Joob1, Viroj Wiwanitkit.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25743126      PMCID： PMC4357374          DOI： 10.1631/jzus.B1500035

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN： 1673-1581            Impact factor:   3.066


× No keyword cloud information.
  11 in total

Review 1.  Ebola virus disease: potential use of melatonin as a treatment.

Authors:  Dun-Xian Tan; Ahmet Korkmaz; Russel J Reiter; Lucien C Manchester
Journal:  J Pineal Res       Date:  2014-10-14       Impact factor: 13.007

2.  Dose regimen of favipiravir for Ebola virus disease.

Authors:  France Mentré; Anne-Marie Taburet; Jeremie Guedj; Xavier Anglaret; Sakoba Keïta; Xavier de Lamballerie; Denis Malvy
Journal:  Lancet Infect Dis       Date:  2014-11-28       Impact factor: 25.071

3.  Antibody therapy to limit the spread of Ebola virus.

Authors:  Bracha Rager-Zisman
Journal:  Isr Med Assoc J       Date:  2014-12       Impact factor: 0.892

4.  Could interferon help treat Ebola?

Authors:  Miriam Shuchman
Journal:  CMAJ       Date:  2014-09-22       Impact factor: 8.262

5.  Forty years of the war against Ebola.

Authors:  Lei Zhang; Hao Wang
Journal:  J Zhejiang Univ Sci B       Date:  2014-09       Impact factor: 3.066

6.  Favipiravir: a new medication for the Ebola virus disease pandemic.

Authors:  Takashi Nagata; Alan K Lefor; Manabu Hasegawa; Masami Ishii
Journal:  Disaster Med Public Health Prep       Date:  2014-12-29       Impact factor: 1.385

Review 7.  Ebola virus: melatonin as a readily available treatment option.

Authors:  George Anderson; Michael Maes; Regina P Markus; Moses Rodriguez
Journal:  J Med Virol       Date:  2015-01-21       Impact factor: 2.327

8.  Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model.

Authors:  Lisa Oestereich; Anja Lüdtke; Stephanie Wurr; Toni Rieger; César Muñoz-Fontela; Stephan Günther
Journal:  Antiviral Res       Date:  2014-02-26       Impact factor: 5.970

9.  Interferon-β therapy prolongs survival in rhesus macaque models of Ebola and Marburg hemorrhagic fever.

Authors:  Lauren M Smith; Lisa E Hensley; Thomas W Geisbert; Joshua Johnson; Andrea Stossel; Anna Honko; Judy Y Yen; Joan Geisbert; Jason Paragas; Elizabeth Fritz; Gene Olinger; Howard A Young; Kathleen H Rubins; Christopher L Karp
Journal:  J Infect Dis       Date:  2012-12-18       Impact factor: 5.226

10.  Against Ebola: type I interferon guard risk and mesenchymal stromal cell combat sepsis.

Authors:  Lei Zhang; Hao Wang; Yi-qing Zhang
Journal:  J Zhejiang Univ Sci B       Date:  2015-01       Impact factor: 3.066
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.